Julia KolleweJournalist
The Guardian
Health & social care coverage read by Vital Signs
22 articles
Across 3 topics, first on 11 Sept 2025, most recently 6 Jul 2026.
This counts only pieces our coverage scan read on the topics Vital Signs tracks, not their full output.
Biography
Julia Kollewe writes about pharmaceuticals, property and insurance for the Guardian and the Observer, and often covers breaking City news as well. She previously worked at the Independent, Bloomberg News and Market News International
Their Guardian profile ↗Biography and photograph published by The Guardian itself
What they cover
Who they quote
Voices credited in their pieces. A reporter who has called someone before is likely to call them again.
- Jim MackeyRegulator1 article
- Tom BrailsfordSector leader1 article
- Richard SullivanAcademic1 article
- Liz BreenAcademic1 article
- Olivia SteeleSector leader1 article
- Dr Carel Le RouxAcademic1 article
- David WeeksSector leader1 article
- Mark SamuelsSector leader1 article
- Wouter DewulfAcademic1 article
- Frank Van GelderSector leader1 article
- Dr Katie KingAcademic1 article
- Lone FriisClinician1 article
- Hesham AbdullahSector leader1 article
- Richard TorbettSector leader1 article
- Olivier PicardSector leader1 article
- Professor Victoria Tzortziou BrownClinician1 article
- Sir John BellAcademic1 article
- Sharon ToddSector leader1 article
- Dr Zubir AhmedRegulator1 article
- Abdal AlviAcademic1 article
- Dr Eric PerakslisAcademic1 article
- Dr Jennifer HwangAcademic1 article
Recent articles
- Wegovy weight-loss pill goes on sale on UK high street and online pharmacies
The GuardianPublic health & prevention6 Jul 2026
- NHS patients face worst drug shortages on record, say pharmacists and GPs
The GuardianHospital discharge / bed-blocking18 Jun 2026
- London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’
The GuardianCancer14 Jun 2026
- GSK makes biggest ever acquisition with $10.6bn for US cancer drug firm
The GuardianCancer9 Jun 2026
- Final frontier for meds? UK startup sends drug-making into space
The GuardianCancer23 May 2026
- ‘Research here is world class’: son of Steve Jobs looks to invest in UK cancer care
The GuardianCancer16 May 2026
- From syringes to stents: Iran war exposes NHS dependency on petrochemicals
The GuardianHospital discharge / bed-blocking26 Apr 2026
- GSK reports promising early results in ovarian and womb cancer drug trial
The GuardianCancer12 Apr 2026
- UK ‘weeks away’ from medicine shortages if Iran war continues, experts say
The GuardianHospital discharge / bed-blocking28 Mar 2026
- Weight-loss race: how switch from injections to pills is expanding big pharma’s hopes
The GuardianPublic health & prevention15 Feb 2026
- AstraZeneca CEO hails NHS drug price deal but keeps pause on £200m UK investment
The GuardianHospital discharge / bed-blocking10 Feb 2026
- Wegovy and Ozempic maker forecasts sharp drop in revenue for 2026
The GuardianPublic health & prevention4 Feb 2026
- Software firm belonging to Tory donor Frank Hester pays out £50m dividend
The GuardianHospital discharge / bed-blocking8 Jan 2026
- US is the best place for drug companies to invest, says boss of London-based GSK
The GuardianHospital discharge / bed-blocking11 Dec 2025
- UK officials ‘working day and night’ to resolve NHS drug pricing row’
The GuardianHospital discharge / bed-blocking17 Nov 2025
- UK must reform drug pricing to become life sciences superpower, says GSK boss
The GuardianHospital discharge / bed-blocking29 Oct 2025
- Wegovy maker Novo Nordisk’s chair and six other board members step down
The GuardianPublic health & prevention21 Oct 2025
- Thousands in UK take legal action against Johnson & Johnson over alleged talc cancer link
The GuardianCancer16 Oct 2025
- NHS could pay 25% more for medicines under plan to end row with drugmakers and Trump
The GuardianHospital discharge / bed-blocking8 Oct 2025
- UK set on resolving standoff with big pharma, science minister says
The GuardianHospital discharge / bed-blocking16 Sept 2025
Showing the 20 most recent of 22 pieces read.
Bylines and quoted sources are read automatically from UK coverage of the topics Vital Signs tracks, so this page reflects what our scan has read rather than a complete record. Where a biography and photograph appear, they are published by the outlet itself about its own correspondent, and linked above. Social accounts are not held: asserting an unverified one would attach a real person to an account that might not be theirs. See the methodology, or email contact@bridgeheadcommunications.com to correct anything on it.